Advertisement

Ads Placeholder
Loading...

Merck & Co., Inc.

MRKNYSE
Healthcare
Drug Manufacturers - General
$120.87
$0.03(0.02%)
U.S. Market opens in 4h 13m

Merck & Co., Inc. (MRK) Stock Overview

Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap298.8B
P/E Ratio16.49
EPS (TTM)$7.27
ROE0.36%
Fundamental Analysis

AI Price Forecasts

1 Month$108.17
3 Months$108.54
1 Year Target$136.48

MRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Merck & Co., Inc. (MRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $136.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.49 and a market capitalization of 298.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.02%
5-Day Change
1.32%
1-Month Change
0.87%
3-Month Change
13.55%
6-Month Change
35.52%
Year-to-Date (YTD) Change
13.55%
1-Year Change
39.91%
3-Year Change
11.02%
5-Year Change
64.63%
All-Time (Max) Change
30471.36%

Contact Information

908 740 4000
126 East Lincoln Avenue, Rahway, NJ, 07065

Company Facts

730,000 Employees
IPO DateJan 13, 1978
CountryUS
Actively Trading

Frequently Asked Questions